NCT02763839
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Human Pharmacology Unit - BIAL - Portela & Ca, S.A. S. Mamede Do Coronado, Portugal
Clinical trial condition
Synucleinopathies
Explore clinical trials studying Synucleinopathies. Study availability and eligibility vary by location and protocol.
3,496 public trials
645 recruiting studies
Synucleinopathies trial results
NCT02763852
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Human Pharmacology Unit - BIAL - Portela & Ca, S.A. S. Mamede Do Coronado, Portugal
NCT00847431
- Conditions
- Anxiety, Anxiety Disorders, Basal Ganglia Diseases, +13 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- University of Cincinnati, Movement Disorder Center Cincinnati, Ohio, United States
NCT02152319
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
- University of Rochester Rochester, New York, United States
NCT02312908
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Completed
A Treadmill Training Program Augmented by Virtual Reality to Decrease Fall Risk in Older Adults
NCT01732653
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
- Locations
-
- Department of Rehabilitation Sciences, Katholieke Universiteit Leuven Leuven, Belgium
- Tel Aviv Sourasky Medical Center Tel Aviv, Israel
- Department of Neurosciences Universita Degli Studi Di Genova, Italy Genova, Italy
- Department of Geriatric Medicine and Neurology, Radboud University Nijmegen Medical Center The Netherlands Nijmegen, Netherlands
Completed
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
NCT00888004
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
- Locations
-
- Novartis Investigative Site Dresden, Germany
- Novartis Investigative Site Kassel, Germany
- Novartis Investigative Site Leun-Biskirchen, Germany
- Novartis Investigative Site Marburg, Germany
NCT02738528
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
Not specified
NCT01944436
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Butyrylcholinesterase deficiency, +14 more
- Locations
-
- Sunnybrook Health Sciences Centre Toronto, Ontario, Canada
NCT00936676
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +7 more
- Locations
-
- Teva Investigational Site 7054 Birmingham, Alabama, United States
- Teva Investigational Site 7006 Tucson, Arizona, United States
- Teva Investigational Site 7018 Irvine, California, United States
- Teva Investigational Site 7019 La Jolla, California, United States